Search Results 1901-1910 of 21389 for anti-TNF drugs

1. Cardiac Regeneration - Center for Regenerative Biotherapeutics - Mayo Clinic Research

   Stem cell therapy is already a treatment option for patients with advanced heart failure due to heart attack. Now, new discoveries are underway to improve stem ...

2. Publications - Scott C. Lester, M.D. - Mayo Clinic

   Incorporating radiation with anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach.

3. Support patients' return to sexual health following cancer treatment - Mayo Clinic

   Communicating with patients and providing support for their sexual health concerns following cancer treatment is important for their overall recovery and ...

4. Rocuronium (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

5. Fentanyl (Injection Route) Description and Brand Names - Mayo Clinic

   Fentanyl belongs to the group of medicines called opioid analgesics (pain medicines). It acts in the central nervous system (CNS) or brain to relieve pain.

6. Pancreatic Cancer Clinical Trials - Mayo Clinic Research

   Cystic tumors of the pancreas are fluid-filled growths. They are often treated by surgical removal. A safe and effective non-surgical treatment is desirable.

7. Pentoxifylline (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Pentopak; Pentoxil; TRENtal. Descriptions.

8. Tigecycline (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

9. Olanzapine And Fluoxetine (Oral Route) Description and Brand Names - Mayo Clinic

   Olanzapine is an antipsychotic agent. Fluoxetine is an antidepressant and belongs to a group of medicines known as selective serotonin reuptake inhibitors ( ...

10. A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER) - Mayo Clinic

    A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER). Print ...